Inventor · disambiguated record
Jalahej Heyman
Also filed as: Heyman Jalahej
1 granted patent·6 pending applications·0 citations·filing 2015–2024
14Inventor score
Top patents by PatentIndex Score
7 records- 0161US2024316168A1Immunomodulatory Therapy For Type 1 Diabetes Mellitus AutoimmunityPHAIM PHARMA LTD·Filed 2024·Application pending·0 cites
- 0257US2024361217A1Psoriasis and Other Autoimmune Diseases Antigen Immune Modulator (AIM) Therapeutic PlatformPHAIM PHARMA LTD·Filed 2024·Application pending·0 cites
- 0349US2021353727A1Immunomodulatory therapy for type 1 diabetes mellitus autoimmunityPHAIM PHARMA LTD·Filed 2021·Application pending·0 cites
- 0446US11040093B2Immunomodulatory therapy for type 1 diabetes mellitus autoimmunityORBAN TIHAMER·Filed 2015·Granted Jun 22, 2021·0 cites·11 claims
- 0545US2024277768A1Individualized Cell Therapy Using Patient-Derived Antigen-Specific Regulatory T CellsORBAN TIHAMER·Filed 2022·Application pending·0 cites
- 0645US2021404921A1Psoriasis and other autoimmune diseases antigen immune modulator (aim) therapeutic platformPHAIM PHARMA LTD·Filed 2021·Application pending·0 cites
- 0740US2024285732A1Patient Profiling for Antigen-Specific Immunomodulatory TherapiesPHAIM PHARMA LTD·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jalahej Heyman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →